The Non-Malignant Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Betibeglogene autotemcel for β-Thalassemia
Christian Chabannon
• 26 Mar 2019
In this video, Christian Chabannon, MD, PhD, of Institut Paoli-Calmettes, Marseille, France, speaks about betibeglogene autotemcel (formerly LentiGlobin BB305) for β-Thalassemia. Prof. Chabannon was talking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
